Check out the sessions we covered at GTT on November 16, 2021!
Session 1: Global Regulatory Update
- Recent FDA Guidance on:
- Suspect & Illegitimate Product
- Product Identifiers
- Enhanced Drug Distribution
- PDG Workshops for 2023 Interoperability
- Rapid Fire Market Updates (Brazil, China, Russia, etc.)
Session 2: Brand Protection Panel Discussion
- Never Too Early: Why companies big and small, newly launched or long-established, need to be thinking about illicit trade risk
- Partnering for Protection: How and why competitors are collaborating to protect their patients and brands from illicit trade
Session 3: Europe Focused Discussion
- Going to the EU: Launching first product in EU and what does that mean? What do you have to do? Register? Updating your labels?
- Alert Management
- Identification of Medicinal Products (IDMP)
- Brexit
Session 4: Value Applications
- Enhanced Traceability Solutions
- Supply Chain Digitalization